Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion type Assertion NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_head.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion description "[Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_provenance.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion evidence source_evidence_literature NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_provenance.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion SIO_000772 25492619 NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_provenance.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion wasDerivedFrom befree-2016 NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_provenance.
- NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_assertion wasGeneratedBy ECO_0000203 NP1246671.RAmnvBCjdK0p485ooWlrPNB78CgU_jqTMuWtcmqv-BTSM130_provenance.